BioNTech SE (BNTX) Announces 5M Share Proposed Public Offerings of ADSs and Rights Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/5/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
BioNTech SE (BNTX) files to offer 5 Million ADSs and 750K for selling shareholders
July 21, 2020 8:27 AM EDTBioNTech SE (NASDAQ: BNTX) files to offer 5 Million ADSs and 750K for selling shareholders.
From the filing:
We are offering 5,000,000 American Depositary Shares,... More
BofA Securities Upgrades BioNTech (BNTX) to Buy as Positive Vaccine Updates Likely to Continue
July 21, 2020 4:19 AM EDT(Updated - July 21, 2020 6:53 AM EDT)
(updated to add analyst comments)
BofA Securities analyst Tazeen Ahmad upgraded BioNTech (NASDAQ: BNTX) from Neutral to Buy with a price target of $105 (from $71), saying the company's vaccine program with Pfizer is starting to differentiate... More
Pfizer (PFE), BioNTech SE (BNTX) Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study
July 20, 2020 8:46 AM EDTBioNTech SE (Nasdaq: BNTX) and Pfizer Inc. (NYSE: PFE) today announced initial data from their ongoing German Phase 1/2, open-label, non-randomized, non-placebo-controlled, dose-escalation trial, that is part of the global mRNA-based vaccine program against SARS-CoV-2. The data are... More
